- The vibrant biotech sector is ready to showcase what European businesses can do when it comes to human health while waiting for more initiatives at the policy level.
- Other applications of biotech in healthcare range from personalised medicines to biomarker testing which looks for genes, proteins, and other substances that can provide information about cancer, not to mention the Advanced Therapy Medicinal Products (ATMPs), a term that is interchangeably used as cell and gene therapies.
- In Italy, biotech companies that deal with health-related applications account for 48% of the total, a percentage that increases to 58% for those companies dedicated to biotech R&D – which also engage 75% or more of their total research costs in biotech activities.
High hopes for EU’s health biotech sector after COVID boost
